H.C. Wainwright Reaffirms Their Buy Rating on Argenx Se (ARGX)


H.C. Wainwright Reaffirms Their Buy Rating on Argenx Se (ARGX)

Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter

Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Argenx Se, and scPharmaceuticals. According to TipRanks, Tsao has an average return of 6.8% and a 36.71% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Argenx Se with a $749.93 average price target, representing a 32.58% upside. In a report released on May 15, Stifel Nicolaus also maintained a Buy rating on the stock with a $780.00 price target.

The company has a one-year high of $678.21 and a one-year low of $356.38. Currently, Argenx Se has an average volume of 412.5K.

Previous articleNext article

POPULAR CATEGORY

corporate

12402

tech

11464

entertainment

15420

research

7116

misc

16272

wellness

12511

athletics

16329